These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8866800)

  • 1. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Hengel RL; Kennedy MS; Steketee RW; Thea DM; Abrams EJ; Lambert G; McDougal JS
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):475-81. PubMed ID: 9566549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
    Scarlatti G; Leitner T; Hodara V; Halapi E; Rossi P; Albert J; Fenyö EM
    AIDS; 1993 Nov; 7 Suppl 2():S45-8. PubMed ID: 8161445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of HIV-1 that could influence maternal-child transmission.
    Kliks SC; Wara DW; Landers DV; Levy JA
    JAMA; 1994 Aug; 272(6):467-74. PubMed ID: 8040983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina.
    Calarota SA; Libonatti OV
    Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    Tu JJ; Kumar A; Giorgi EE; Eudailey J; LaBranche CC; Martinez DR; Fouda GG; Moreau Y; Thomas A; Montefiori D; Gao F; Sagar M; Permar SR
    J Virol; 2022 Jun; 96(11):e0023122. PubMed ID: 35536018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immunity in maternal-infant HIV-1 transmission.
    Jansson M; Orlandi P; Scarlatti G; Moschese V; Romiti ML; Cancrini C; Mancia L; Livadiotti S; Castelli-Gattinara G; Rossi P; Halapi E
    Acta Paediatr Suppl; 1997 Jun; 421():39-45. PubMed ID: 9240856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1.
    Chaillon A; Wack T; Braibant M; Mandelbrot L; Blanche S; Warszawski J; Barin F
    J Virol; 2012 Oct; 86(19):10540-6. PubMed ID: 22811522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.
    Bongertz V; Costa CI; Veloso VG; Grinsztejn B; João Filho EC; Calvet G; Pilotto JH; Guimarães ML; Morgado MG
    Scand J Immunol; 2001 Mar; 53(3):302-9. PubMed ID: 11251889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.
    Jenkins M; Landers D; Williams-Herman D; Wara D; Viscarello RR; Hammill HA; Kline MW; Shearer WT; Charlebois ED; Kohl S
    J Infect Dis; 1994 Aug; 170(2):308-12. PubMed ID: 8035015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype.
    Husson RN; Lan Y; Kojima E; Venzon D; Mitsuya H; McIntosh K
    J Pediatr; 1995 Jun; 126(6):865-71. PubMed ID: 7776085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
    Ugen KE; Goedert JJ; Boyer J; Refaeli Y; Frank I; Williams WV; Willoughby A; Landesman S; Mendez H; Rubinstein A
    J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
    Scarlatti G; Albert J; Rossi P; Hodara V; Biraghi P; Muggiasca L; Fenyö EM
    J Infect Dis; 1993 Jul; 168(1):207-10. PubMed ID: 8515110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.
    Dickover R; Garratty E; Yusim K; Miller C; Korber B; Bryson Y
    J Virol; 2006 Jul; 80(13):6525-33. PubMed ID: 16775339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.